According to a new study published in the journal Heart, average or brisk walking paces were associated with 35-43 per cent ...

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), ...

While the risk of cardiovascular outcomes following SARS-CoV-2 infection has been reported in adults, a new study showed t ...

CV evaluation included history, PE, 12-lead and ... In addition, ventricular (polymorphic, couplets or non-sustained ventricular tachycardia) or supraventricular tachyarrhythmias (atrial flutter, ...

The differences in risk of sudden cardiac death varied by age and how long people took antidepressants, with people taking ...

Stock analysts at HC Wainwright lifted their Q1 2025 earnings estimates for Milestone Pharmaceuticals in a report issued on Tuesday, April 1st. HC Wainwright analyst P. Trucchio now anticipates that ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

They also looked into whether people had filled a prescription for an antidepressant at least twice in one year over 12 years leading ... which can lead ultimately to sudden cardiac death ...

Shares of Edgewise Therapeutics EWTX plunged 47.7% in a week, likely due to safety concerns for its investigational candidate ...

It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession sparked by the ongoing global trade war. Most bigwigs came out with important ...

the reduced flow of blood to the brain can also lead to non-epileptic seizures, which can easily be confused for epilepsy. Left untreated, ventricular tachycardia can trigger a medical emergency known ...